Downingtown, PA, United States of America

David J Cooper

USPTO Granted Patents = 9 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Downingtown, PA (US) (1976 - 1983)
  • Phoenixville, PA (US) (1981 - 1983)

Company Filing History:


Years Active: 1976-1983

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David J Cooper

Introduction

David J Cooper is a notable inventor based in Downingtown, PA, with a remarkable portfolio of nine patents. His work primarily focuses on the development of antibiotics, showcasing his commitment to advancing medical science and improving health outcomes.

Latest Patents

Among his latest patents, Cooper has developed amino glycoside antibiotics that possess antiprotozoal and anthelmintic properties. In the fermentation production of gentamicin C, a variety of additional antibiotic compounds are produced. Four of these compounds—gentamicin A, gentamicin B, gentamicin B.sub.1, and gentamicin X—demonstrate significant anti-protozoal and anthelmintic activity. Notably, gentamicin B and B.sub.1 also exhibit substantial antibacterial properties with markedly reduced side effects. Another significant patent involves anthracycline antibiotics produced by Streptosporangium fragile. This novel anthracycline antibiotic complex, known as fragilomycin complex, is generated through the cultivation of a fermentation broth containing Streptosporangium fragile Shearer sp. nov. ATCC 31519 microorganisms in an aqueous nutrient medium under submerged aerobic conditions. The fragilomycin complex, along with its major bioactive component, fragilomycin A, showcases antibiotic activity.

Career Highlights

Throughout his career, David J Cooper has made significant contributions to the field of antibiotic research. He has worked with prominent companies such as SmithKline Corporation and Schering Corporation, where he has applied his expertise in developing innovative pharmaceutical solutions.

Collaborations

Cooper has collaborated with esteemed colleagues, including Joseph R Valenta and Jay A Waitz, further enhancing the impact of his work in the field of antibiotics.

Conclusion

David J Cooper's innovative contributions to antibiotic development have made a significant impact on medical science. His dedication to research and collaboration continues to inspire advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…